Cargando…
Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma
Hepatoblastoma is a malignant tumor in the liver of children that generally occurs at the age of 2–3 years. There have been ample evidence from the preclinical as well as clinical studies suggesting the activation of Wnt/β-catenin signaling in hepatoblastoma, which is mainly attributed to the somati...
Autores principales: | Sha, Ying-Li, Liu, Shuang, Yan, Wen-Wen, Dong, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757184/ https://www.ncbi.nlm.nih.gov/pubmed/31511432 http://dx.doi.org/10.1042/BSR20192466 |
Ejemplares similares
-
MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β‐catenin and Wnt signaling
por: Indersie, Emilie, et al.
Publicado: (2017) -
The Emerging Roles of Cancer Stem Cells and Wnt/Beta-Catenin Signaling in Hepatoblastoma
por: Mavila, Nirmala, et al.
Publicado: (2019) -
Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
por: Jung, Youn-Sang, et al.
Publicado: (2020) -
Targeting the Wnt/β-catenin signaling pathway in cancer
por: Zhang, Ya, et al.
Publicado: (2020) -
New Advances in Canonical Wnt/β-Catenin Signaling in Cancer
por: Wen, Xiaolan, et al.
Publicado: (2020)